Prospects for personalizing antiviral therapy for hepatitis C virus with pharmacogenetics.
about
HCV genome-wide genetic analyses in context of disease progression and hepatocellular carcinoma.Cell penetrable humanized-VH/V(H)H that inhibit RNA dependent RNA polymerase (NS5B) of HCV.Prediction of linear B-cell epitopes of hepatitis C virus for vaccine developmentHepatitis C virus infection modulates expression of interferon stimulatory gene IFITM1 by upregulating miR-130A.IL28B polymorphism and genetic biomarkers of viral clearance in hepatitis C virus infection.The role of pharmacogenetics in the treatment of chronic hepatitis C infection.HLA-B*15:02 is associated with anemia in patients with chronic hepatitis C treated with pegylated interferon-α and ribavirin.
P2860
Q33982230-110C75A1-F613-408D-88D5-2F3C30DF7660Q34474314-80C0D754-8901-4667-AD0B-4CE59CCC0EFAQ35872361-5678CD05-B821-4135-98C9-63B5AD08CF4DQ36246282-AF6A317B-9E3F-4003-B829-CD18B598752DQ37921307-6756DD93-D21D-43C7-A8CF-78701B697FA9Q38151586-9793E60C-711B-4AC8-AF86-C9D7EB3CB5A3Q42983742-35E4DCDF-F3D0-46DA-83AA-38475EC32FA9
P2860
Prospects for personalizing antiviral therapy for hepatitis C virus with pharmacogenetics.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Prospects for personalizing an ...... C virus with pharmacogenetics.
@en
Prospects for personalizing an ...... C virus with pharmacogenetics.
@nl
type
label
Prospects for personalizing an ...... C virus with pharmacogenetics.
@en
Prospects for personalizing an ...... C virus with pharmacogenetics.
@nl
prefLabel
Prospects for personalizing an ...... C virus with pharmacogenetics.
@en
Prospects for personalizing an ...... C virus with pharmacogenetics.
@nl
P2860
P50
P356
P1433
P1476
Prospects for personalizing an ...... C virus with pharmacogenetics.
@en
P2093
John E Tavis
Xiaofeng Fan
P2860
P2888
P356
10.1186/GM222
P577
2011-02-08T00:00:00Z
P5875
P6179
1037884049